PriceTargets.com logo

Raffles Medical Group - RAFLF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.74 As of 05/1/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for RAFLF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Raffles Medical Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RAFLF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RAFLF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Raffles Medical Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.74.

This chart shows the closing price for RAFLF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Raffles Medical Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/7/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/8/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/6/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/2/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/1/2023NomuraUpgradeNeutral ➝ Buy
3/1/2023Credit Suisse GroupUpgradeNeutral ➝ Outperform
(Data available from 5/2/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/3/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/2/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Raffles Medical Group

Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, Investment Holdings, and Insurance Services segments. Its Raffles Hospital, a tertiary care hospital that offers a range of medical and surgical facilities include day angiography suites, operating theatres, delivery suites, intensive care unit, neonatal intensive care unit, radiology, clinical laboratory, and dental services. In addition, the company offers emergency services, family medicine services, health screening, minor surgery, and various specialist clinic services. Further, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; and provides management and consultancy services. Additionally, the company engages in the operation of medical and dental clinics and other general medical services; provides medical examination and treatment services; operation of medical laboratory and imaging centre; and provision of health insurance services. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. The company operates as a subsidiary of Raffles Medical Holdings Pte Ltd.
Read More

Today's Range

Now: $0.74
Low: $0.74
High: $0.74

50 Day Range

MA: $0.74
Low: $0.73
High: $0.74

52 Week Range

Now: $0.74
Low: $0.73
High: $0.83

Volume

N/A

Average Volume

600 shs

Market Capitalization

N/A

P/E Ratio

4.70

Dividend Yield

1.52%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Raffles Medical Group?

The following equities research analysts have issued reports on Raffles Medical Group in the last twelve months: Nomura.
View the latest analyst ratings for RAFLF.

What is the current price target for Raffles Medical Group?

0 Wall Street analysts have set twelve-month price targets for Raffles Medical Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Raffles Medical Group in the next year.
View the latest price targets for RAFLF.

What is the current consensus analyst rating for Raffles Medical Group?

Raffles Medical Group currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RAFLF will outperform the market and that investors should add to their positions of Raffles Medical Group.
View the latest ratings for RAFLF.

What other companies compete with Raffles Medical Group?

Other companies that are similar to Raffles Medical Group include American Oncology Network, American Oncology Network, Bangkok Dusit Medical Services Public, Bumrungrad Hospital Public and CareRx. Learn More about companies similar to Raffles Medical Group.

How do I contact Raffles Medical Group's investor relations team?

Raffles Medical Group's physical mailing address is 585 North Bridge Road, Raffles Hospital, No. 11-00, Singapore 188770, Singapore. The company's listed phone number is (656) 311-1111. The official website for Raffles Medical Group is tel:6563111111. Learn More about contacing Raffles Medical Group investor relations.